Advances and applications of induced pluripotent stem cells

Authors: Pietronave, Stefano; Prat, Maria

Source: Canadian Journal of Physiology and Pharmacology, Volume 90, Number 3, March 2012 , pp. 317-325(9)

Publisher: NRC Research Press

Buy & download fulltext article:

OR

Price: $50.00 plus tax (Refund Policy)

Abstract:

Direct reprogramming of somatic cells into pluripotent cells is an emerging technology for creating patient-specific cells, and potentially opens new scenarios in medical and pharmacological fields. From the discovery of Shinya Yamanaka, who first obtained pluripotent cells from fibroblasts by retrovirus-derived ectopic expression of defined embryonic transcription factors, new methods have been developed to generate safe induced pluripotent stem (iPS) cells without genomic manipulations. This review will focus on the recent advances in iPS technology and their application in pharmacology and medicine.

Keywords: drug discovery; découverte de médicaments; iPS; médecine régénérative; regenerative medicine; retrovirus; rétrovirus

Document Type: Research Article

DOI: http://dx.doi.org/10.1139/y11-125

Affiliations: Laboratory of Histology, Department of Health Sciences, Università del Piemonte Orientale “A. Avogadro”, Via Solaroli 17, 28100 Novara, Italy.

Publication date: March 16, 2012

More about this publication?
  • Published since 1929, this monthly journal reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Terms & Conditions
  • Sample Issue
  • Reprints & Permissions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page